As surgeons gain increased clinical experience with the transverse rec
tus abdominis myocutaneous (TRAM) flap, or autologous breast reconstru
ction, technical modifications aimed at improving flap reliability con
tinue to evolve. These modifications have allowed the TRAM flap to be
performed safely in a higher-risk patient population. The delayed TRAM
flap appears to have an augmented arterial supply and a lesser degree
of venous congestion following division of the deep inferior epigastr
ic vessels 2 weeks prior to reconstruction. Ischemia-related complicat
ions have been reduced in high-risk patients with the use of the delay
ed TRAM.